Cathepsin-D, Urokinase Plasminogen Activator and Type-1 Plasminogen Activator Inhibitor in Early Breast Cancer: An Immunohistochemical Study of Prognostic Value and Relations to Tenascin-C and Other Factors

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6990336
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Interaction of Single-Chain Urokinase and Plasminogen Activator Inhibitor Type 1

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1995English

Accessibility of Receptor-Bound Urokinase to Type-1 Plasminogen Activator Inhibitor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1989English

Prognostic Value of Tissue-Type Plasminogen Activator (tPA) and Its Complex With the Type-1 Inhibitor (PAI-1) in Breast Cancer

British Journal of Cancer
Cancer ResearchOncology
1999English

Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Contribute to Sonic Hedgehog-Induced in Vitro Cerebral Angiogenesis

PLoS ONE
Multidisciplinary
2012English

Imaging Active Urokinase Plasminogen Activator in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2015English

Breast Cancer and Metabolic Syndrome Linked Through the Plasminogen Activator Inhibitor-1 Cycle

BioEssays
BiochemistryGeneticsMolecular Biology
2007English

Retraction: The Effects of Residual Platelets in Plasma on Plasminogen Activator Inhibitor-1 and Plasminogen Activator Inhibitor-1-Related Assays

PLoS ONE
Multidisciplinary
2018English

Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency

Haemophilia
MedicineGeneticsHematology
2019English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy